Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Fast Mapping: How to acquire new declarative memories independently from the Hippocampus?

FAST MAPPING

Current theories of declarative memory suggest that it is supported by two complementary memory systems: the medial temporal lobe (MTL) which specializes in rapid acquisition of novel associations and the neocortex, which slowly learns through environmental regularities. Gilboa et al. recently reported an extraordinary phenomenon of rapid...

Funding Programme
Start Date
End Date
Total Funding
€ 244 670
European Countries Involved

Fast transformation between episodic and semantic memories: Interactions between the hippocampal formation and related regions and their breakdown in Alzheimer’s disease

TRANSMEM

'Our memories define who we are and allow us to live independently. Conscious memory is commonly split into two components; “episodic memory” for events that are specific in time and place, and “semantic memory” for our conceptual knowledge about the world. The acquisition of both episodic and semantic memories depends upon the hippocampal...

Funding Programme
Start Date
End Date
Total Funding
€ 1 169 788
European Countries Involved

FROM PATIENT DATA TO PERSONALISED HEALTHCARE IN ALZHEIMER'S DISEASE

PredictAD

Dementia causes long and oppressive suffering to patients and their relatives and imposes enormous costs on society. About 25 million people suffered from dementia in 2000. As a 4-fold increase of this number is expected by 2050, dementia is one main health issue of the next decades. Alzheimer's disease (AD) covers 60-70% of all dementia cases. No...

Funding Programme
Start Date
End Date
Total Funding
€ 3 908 233
European Countries Involved

Functional and synaptic deficits in cerebral cortical neurons in Alzheimer’s Disease model mice

AD SYNAPTIC DEFICITS

Alzheimer’s disease (AD) is the most common neurodegenerative disease, affecting millions of people worldwide and therefore it is fundamental to understand its underlying mechanisms. Although the neuropathologies involved in AD are well-described, the effect of those pathologies on neuronal function are poorly understood. Using a transgenic mouse...

Funding Programme
Start Date
End Date
Total Funding
€ 45 000
European Countries Involved

Functional evaluation of newly identified deregulated genes in Alzheimer's Disease patients using neuronal cultures and mouse model of the Disease, and possible contributions to Prion Disease

AdAPtoGENE

Neurodegenerative diseases (NDs) are the neurological disorders which will affect a significantly growing number of people in the context of the aging of the EU's population and worldwide. NDs thus constitute a priority for action. Alzheimer’s Disease (AD) is the most common form of dementia and ND, and a major social and health problem...

Funding Programme
Start Date
End Date
Total Funding
€ 168 896
European Countries Involved

Generalised EMF Research using Novel Methods – an integrated approach: from research to risk assessment and support to risk management

GERONIMO

The EU population is increasingly exposed to new physical and chemical agents in the environment, some of which may be detrimental to public health. Of these, electromagnetic fields (EMF) are one of the most ubiquitous, with new EMF technologies and novel applications being actively developed and commercialised. To address pertinent questions on...

Funding Programme
Start Date
End Date
Total Funding
€ 7 853 407

Grammar and memory: Evidence from agrammatic aphasia and probable Alzheimer's disease in German, Italian and Greek

MemoGram

In Europe, there is an increasing number of people with neurological problems, such as probable Alzheimer’s disease (pAD) or aphasia, which often result in severe language and memory impairments. It has been argued that memory deficits contribute to the language problems brain-damaged populations face and, further, can predict these populations’...

Funding Programme
Start Date
End Date
Total Funding
€ 216 953
European Countries Involved

GSK-3 in neuronal plasticity and neurodegeneration: basic mechanisms and pre-clinical assessment

NEURO.GSK3

Neuronal circuits in mammalian brain act predominantly via excitatory synapses on dendritic spines. Formation of new spines in adult brain constitutes the structural basis of neuronal plasticity. The underlying molecular mechanisms remain largely unknown but depend essentially on kinase-dependent signalling pathways. Final formation of synapses on...

Funding Programme
Start Date
End Date
Total Funding
€ 5 082 027
European Countries Involved

Healthy Aging Through Internet Counselling in the Elderly

HATICE

Diabetes mellitus, hypertension, obesity, hypercholesterolemia, smoking and physical inactivity are common in elderly persons and are all associated with an increased risk of myocardial infarction, stroke and dementia. Efficacious treatments of these cardiovascular diseases are available, but in elderly patients with multiple cardiovascular...

Funding Programme
Start Date
End Date
Total Funding
€ 7 423 520
European Countries Involved

High Resolution Segmentation of Brain MR Images at 7 Teslas

HIRESBRAIN7T

The advent of magnetic resonance imaging (MRI) technology has brought us closer to understanding brain function in health and disease. With 7 Teslas high field MRI machines, pioneers of imaging physics have made possible in-vivo examination of the human brain at sub-millimetre scale. New imaging contrasts additionally offer rich information...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Identification and modulation of pathogenic Amyloid beta-peptide species

AMYLOID

The frequency of Alzheimer's disease (AD) will dramatically increase in the ageing western society during the next decades. Currently, about 18 million people suffer worldwide from AD. Since no cure is available, this devastating disorder represents one of the most challenging socio-economical problems of our future. As onset and progression of AD...

Funding Programme
Start Date
End Date
Total Funding
€ 2 497 020
European Countries Involved

Identification and validation of cerebral KCa3.1/KCa2.3 potassium channels a drug tragets for the prevention and treatment of cerebral ischemia associated with diabetes and Alzheimers disease

BRAINIK

The objectives of the project are to identify and evaluate potassium channels of the KCa3.1/KCa2.X type as novel drug targets for the prevention and treatment of cerebrovascular ischemia and neuroprotection in metabolic disease and neurodegenerative disorders associated with vascular pathologies, as a new pathophysiological concept and treatment...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).